510(k) · Cleared
ClearedCobas Integra Bilirubin Special and Roche/Hitachi Bilrubin Total, Models 20737496 322, 03261638 190, and 11822713 226
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Roche Diagnostics Corp. · CIG Diazo Colorimetry, Bilirubin
Cleared on Dec 22, 2006 as substantially equivalent to K951595 (Roche Diagnostic Systems, Inc., 1995) and 1 other predicate after a 28-day review. Its family tree reaches back 2 generations to 1979. 10 later devices descend from it.
- Decided
- Dec 22, 2006
- Review
- 28 days
- Class
- Class II
- Product code
- CIG
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 2 generations to K781921 (1979). 3 ancestors in all. 10 later devices descend from it, 3 citing it directly.
- Root · 2 generations backK781921 Bilirubin, Dingle Valve DPDBoehringer Mannheim Corp. · 1979
- 1 generation backK981632 Roche Diagnostics, Boehringer Mannheim Liquid Total Bilirubin ReagentRoche Diagnostics/Boehringer Mannheim GmbH · 1998
- This deviceK063543 Cobas Integra Bilirubin Special and Roche/Hitachi Bilrubin Total…Roche Diagnostics Corp. · 2006
- Descendant · cites it directly · 6 of its ownK063744 Cobas Integra C 111Rochdiag · 2007
- Descendant · cites it directly · 1 of its ownK131544 Cobas C Bilirubin Total Gen.3Roche Diagnostics · 2013 · Recalled
- Descendant · 2 generations on · 1 of its ownK122083 Elitech Clinical Systems CK Nac SLElitechgroup · 2012
- Descendant · 2 generations on · 1 of its ownK071211 Cobas C 111 AnalyzerRoche Diagnostics · 2007 · Recalled
- Descendant · 2 generations on · 0 of its ownK251998 Atellica CH Diazo Total Bilirubin (D_TBil)Siemens Healthcare Diagnostics, Inc. · 2026
Showing 5 of 10 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 10 · See all- K063744Cobas Integra C 111Rochdiag · 2007 · cites it directly6descendants
- K131544Cobas C Bilirubin Total Gen.3Roche Diagnostics · 2013 · cites it directly1descendant
- K122083Elitech Clinical Systems CK Nac SLElitechgroup · 2012 · 2 generations on1descendant
- K071211Cobas C 111 AnalyzerRoche Diagnostics · 2007 · 2 generations on1descendant
- K251998Atellica CH Diazo Total Bilirubin (D_TBil)Siemens Healthcare Diagnostics, Inc. · 2026 · 2 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K781921 | Bilirubin, Dingle Valve DPD | Boehringer Mannheim Corp. | 1979 | — |
| −1 | K981632 | Roche Diagnostics, Boehringer Mannheim Liquid Total Bilirubin Reagent | Roche Diagnostics/Boehringer Mannheim GmbH | 1998 | — |
| 0 (this device) | K063543 | Cobas Integra Bilirubin Special and Roche/Hitachi Bilrubin Total, Models… | Roche Diagnostics Corp. | 2006 | — |
| +1 | K063744 | Cobas Integra C 111 | Rochdiag | 2007 | — |
| +1 | K131544 | Cobas C Bilirubin Total Gen.3 | Roche Diagnostics | 2013 | 2 |
| +2 | K122083 | Elitech Clinical Systems CK Nac SL | Elitechgroup | 2012 | — |
| +2 | K071211 | Cobas C 111 Analyzer | Roche Diagnostics | 2007 | 3 |
| +2 | K251998 | Atellica CH Diazo Total Bilirubin (D_TBil) | Siemens Healthcare Diagnostics, Inc. | 2026 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1995 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 2 | 0 |
| 2011 | 2 | 0 |
| 2012 | 2 | 0 |
| 2013 | 2 | 0 |
| 2014 | 1 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in CIG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new CIG device
- #1 K251998 Atellica CH Diazo Total Bilirubin (D_TBil)score 11.8 · 4 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K951595 | Roche Cobas Integra Analyzer, Reagent CassettesSummary page 1…r Bilirubin (Total and Direct) test systems. The reagents were originally cleared for use as: COBAS INTEGRA Bilirubin Direct K95 1595 COBAS INTEGRA Total Bilirubin Special K981632/A00l Roche/Hitachi Total Bilirubin K981632/A0O1… | 1995 |
| * | K981632 | Roche Diagnostics, Boehringer Mannheim Liquid Total Bilirubin ReagentSummary page 1…e reagents were originally cleared for use as: COBAS INTEGRA Bilirubin Direct K95 1595 COBAS INTEGRA Total Bilirubin Special K981632/A00l Roche/Hitachi Total Bilirubin K981632/A0O1 Note that COBAS INTEGRA Total Bilirubin Special an… | 1998 |
What descends from it? (10)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 27 years and passes through 3 companies; a new generation was cleared every 19.4 years on median.
- 1 of the 3 ancestors has a recall of any class.
- Of its descendants, K063744 (Rochdiag, 2007) has gone furthest, with 6 descendants of its own.
- 31 other devices also cite its predicate K951595.
How does its category compare?
All CIG devicesCIG Diazo Colorimetry, Bilirubin: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · CIG
2in 2023
2026 to Oct 25, outlined.
Median 510(k) review, days · CIG
64in 2013
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · CIG
1in 2019
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · CIG
52in 2025
MAUDE reports naming product code CIG, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 2 |
| 2008 | 3 | 199 | 0 | 8 |
| 2009 | 2 | — | 3 | 3 |
| 2010 | 1 | — | 0 | 6 |
| 2011 | 2 | — | 0 | 38 |
| 2012 | 0 | — | 0 | 14 |
| 2013 | 5 | 64 | 3 | 8 |
| 2014 | 0 | — | 0 | 3 |
| 2015 | 1 | — | 0 | 7 |
| 2016 | 0 | — | 0 | 4 |
| 2017 | 1 | — | 0 | 11 |
| 2018 | 0 | — | 0 | 23 |
| 2019 | 1 | — | 1 | 25 |
| 2020 | 0 | — | 0 | 31 |
| 2021 | 0 | — | 0 | 22 |
| 2022 | 1 | — | 0 | 26 |
| 2023 | 2 | — | 0 | 34 |
| 2024 | 0 | — | 0 | 39 |
| 2025 | 0 | — | 0 | 52 |
| 2026 | 1 | — | 0 | — |
What is it indicated for?
COBAS INTEGRA Bilirubin Direct The cassette COBAS INTEGRA Bilirubin Direct (BIL-D) contains an in vitro diagnostic reagent system intended for use on COBAS INTEGRA systems for the quantitative determination of the direct (conjugated) bilirubin concentration in serum and plasma (test BIL-D, 0-049). COBAS INTEGRA Total Bilirubin Special The COBAS INTEGRA Total Bilirubin Special (BILTS) cassette contains an in vitro diagnostic reagent system intended for…
Read the full statement (150 words)
COBAS INTEGRA Bilirubin Direct
The cassette COBAS INTEGRA Bilirubin Direct (BIL-D) contains an in vitro diagnostic reagent system intended for use on COBAS INTEGRA systems for the quantitative determination of the direct (conjugated) bilirubin concentration in serum and plasma (test BIL-D, 0-049).
COBAS INTEGRA Total Bilirubin Special
The COBAS INTEGRA Total Bilirubin Special (BILTS) cassette contains an in vitro diagnostic reagent system intended for use on COBAS INTEGRA systems for the quantitative determination of total bilirubin in serum and plasma of adults and neonates (test BILTS, 0-985).
Roche Hitachi Total Bilirubin Special
For the quantitative determination of total bilirubin in serum and plasma of adults and neonates on Roche/Hitachi automated clinical chemistry analyzers.
Measurement of the levels of bilirubin and organic compound formed during the normal and abnormal distruction of red cells, if used in the diagnosis of liver, hemolytic hemoatological, and metabolic disorders, including hepatitis and gall bladder block
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K063543 · printed Nov 4, 2026
Cite this page
510(k) Report. “K063543: Cobas Integra Bilirubin Special and Roche/Hitachi Bilrubin Total, Models 20737496 322, 03261638 190, and 11822713 226.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K063543
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026